These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3393491)

  • 1. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
    Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma.
    Landström M; Bergh A; Tomic R; Damber JE
    Prostate; 1990; 17(1):57-68. PubMed ID: 1696714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A
    Prostate; 1994 Jul; 25(1):10-8. PubMed ID: 8022707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
    Ip MM; Milholland RJ; Rosen F
    Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology.
    Damber JE; Bergh A; Landström M; Tomić R
    J Urol; 1991 Jun; 145(6):1283-7. PubMed ID: 1827847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen treatment of Dunning tumors in castrated rats: qualitative and quantitative morphology.
    Landström M; Bergh A; Thornell LE; Virtanen I; Damber JE
    Prostate; 1992; 20(3):199-211. PubMed ID: 1574467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R
    J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation.
    Kager M; Spruss T; Schneider MR; von Angerer E
    J Cancer Res Clin Oncol; 1992; 118(5):334-8. PubMed ID: 1583064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of zindoxifene on experimental prostatic tumours of the rat.
    Schneider MR; Schiller CD; Humm A; von Angerer E
    J Cancer Res Clin Oncol; 1991; 117(1):33-6. PubMed ID: 1997466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors.
    Landström M; Eklöv S; Colosetti P; Nilsson S; Damber JE; Bergh A; Funa K
    Int J Cancer; 1996 Aug; 67(4):573-9. PubMed ID: 8759618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 6-methylene progesterone on growth, morphology, and blood flow of the Dunning R3327 prostatic adenocarcinoma.
    Damber JE; Bergh A; Daehlin L; Petrow V; Landström M
    Prostate; 1992; 20(3):187-97. PubMed ID: 1574466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in rats.
    Van Ginckel R; De Coster R; Wouters W; Vanherck W; van der Veer R; Goeminne N; Jagers E; Van Cauteren H; Wouters L; Distelmans W
    Prostate; 1990; 16(4):313-23. PubMed ID: 2371176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the preestrogen 4-androstene-3,17-dion-19-al on the Dunning R3327 prostatic adenocarcinoma.
    Marks TA; Petrow V
    Cancer Res; 1983 Aug; 43(8):3687-90. PubMed ID: 6861138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma.
    Landström M; Tomić R; Damber JE
    Eur Urol; 1987; 13(3):203-6. PubMed ID: 2956111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of oestradiol on growth and morphology of the Dunning R3327H prostatic carcinoma.
    Daehlin L; Bergh A; Damber JE
    Urol Res; 1987; 15(3):169-72. PubMed ID: 3629752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal antiestrogens and partial estrogens with prostatic tumor inhibiting activity.
    Schneider MR; Hartmann RW; Sinowatz F; Amselgruber W
    J Cancer Res Clin Oncol; 1986; 112(3):258-65. PubMed ID: 2946698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tobacco smoke on tumor growth and radiation response of dunning R3327 prostate adenocarcinoma in rats.
    Johansson S; Landström M; Bjermer L; Henriksson R
    Prostate; 2000 Mar; 42(4):253-9. PubMed ID: 10679754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
    Lindström P; Bergh A; Holm I; Damber JE
    Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated Dunning R3327 prostatic adenocarcinoma.
    Westin P; Bergh A; Damber JE
    Prostate; 1993; 22(1):65-74. PubMed ID: 8426839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.